Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer: A Systematic Review

Micro-Abstract Patient-reported outcomes are increasingly important in the evaluation of cancer treatment modalities. We systematically reviewed the existing published data on patient-reported health-related quality of life (HRQOL) after stereotactic ablative radiotherapy (SABR) for early-stage non–...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical lung cancer 2016-09, Vol.17 (5), p.e141-e149
Hauptverfasser:	Chen, Hanbo, Louie, Alexander V, Boldt, R. Gabriel, Rodrigues, George B, Palma, David A, Senan, Suresh
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - radiotherapy Dyspnea - etiology Fatigue - etiology Hematology, Oncology and Palliative Medicine Humans Lung Neoplasms - pathology Lung Neoplasms - radiotherapy Neoplasm Staging Patient-reported outcome Prospective studies Pulmonary/Respiratory Quality of Life Radiosurgery Radiosurgery - adverse effects Radiosurgery - methods SABR Surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Micro-Abstract Patient-reported outcomes are increasingly important in the evaluation of cancer treatment modalities. We systematically reviewed the existing published data on patient-reported health-related quality of life (HRQOL) after stereotactic ablative radiotherapy (SABR) for early-stage non–small-cell lung cancer. Nine studies were analyzed, and our results showed that most HRQOL domains were preserved after SABR. Possible deteriorations in dyspnea and fatigue were noted.
ISSN:	1525-7304 1938-0690
DOI:	10.1016/j.cllc.2015.12.009